Sylvester Comprehensive Cancer Center

  • 20231238 - Bilusic Marijo

  • Investigator:
    Marijo Bilusic
    RCname Email

    Coordinator:

    IRB: 20231238

    SDG: GU
    Disease Site(s):

    Bladder,Kidney,Other Urinary

    Sponsor: Bicycle Therapeutics

    Enrolling Sites:

    Aventura
    Deerfield
    Gables
    Hollywood
    Kendall
    Plantation
    Sylvester
    UMH

    Title:

    A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

    Eligibility Criteria - NCT06225596 *This information has been extracted from " www.clinicaltrials.gov"

  • 20231239 - Bilusic Marijo

  • Investigator:
    Marijo Bilusic
    RCname Email

    Coordinator:

    IRB: 20231239

    SDG: GU
    Disease Site(s):

    Prostate

    Sponsor: MERCK SHARP & DOHME

    Enrolling Sites:

    Aventura
    Coral Springs
    Deerfield
    Gables
    Hollywood
    Kendall
    Plantation
    Sylvester
    UMH

    Title:

    A Phase 3 Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) Previously Treated With Next-generation Hormonal Agent (NHA) and Taxane-based Chemotherapy

    Eligibility Criteria - NCT06136624 *This information has been extracted from " www.clinicaltrials.gov"

  • 20220783 - Gonzalgo Mark

  • Investigator:
    Mark Gonzalgo
    RCname Email

    Coordinator:

    IRB: 20220783

    SDG: GU
    Disease Site(s):

    Kidney

    Sponsor: SCCC

    Enrolling Sites:

    Plantation
    Sylvester
    UMH

    Title:

    NSAID Use after Robotic Partial Nephrectomy (No-PAIN): a randomized, controlled trial

    Eligibility Criteria - NCT05842044 *This information has been extracted from " www.clinicaltrials.gov"

  • 20220852 - Punnen Sanoj

  • Investigator:
    Sanoj Punnen
    RCname Email

    Coordinator:

    IRB: 20220852

    SDG: GU
    Disease Site(s):

    Prostate

    Sponsor: SCCC

    Enrolling Sites:

    Deerfield
    Sylvester
    UMH

    Title:

    Phase 2 Randomized Trial: Human Amnion Membrane Allograft and Early Return of Erectile Function after Radical Prostatectomy (HAMMER)

    Eligibility Criteria - NCT05842057 *This information has been extracted from " www.clinicaltrials.gov"

  • 20240036 - Punnen Sanoj

  • Investigator:
    Sanoj Punnen
    RCname Email

    Coordinator:

    IRB: 20240036

    SDG: GU
    Disease Site(s):

    Prostate

    Sponsor: CURIUM US LLC

    Enrolling Sites:

    Deerfield
    Gables
    Plantation
    Sylvester
    UMH

    Title:

    A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection

    Eligibility Criteria - NCT06235151 *This information has been extracted from " www.clinicaltrials.gov"

  • SWOG S1802 - Ritch, Chad

  • Investigator:
    Chad Ritch
    RCname Email

    Coordinator:

    IRB: 20180970

    SDG: GU
    Disease Site(s):

    Prostate

    Sponsor: SWOG

    Enrolling Sites:

    Deerfield
    Gables
    Sylvester

    Title:

    S1802: PHASE III RANDOMIZED TRIAL OF STANDARD SYSTEMIC THERAPY (SST) VERSUS STANDARD SYSTEMIC THERAPY PLUS DEFINITIVE TREATMENT (SURGERY OR RADIATION) OF THE PRIMARY TUMOR IN METASTATIC PROSTATE CANCER

    Eligibility Criteria - NCT03678025 *This information has been extracted from " www.clinicaltrials.gov"

  • 20220331 - Ritch Chad

  • Investigator:
    Chad Ritch
    RCname Email

    Coordinator:

    IRB: 20220331

    SDG: GU
    Disease Site(s):

    Other Male Genital

    Sponsor: ECOG

    Enrolling Sites:

    Sylvester

    Title:

    EA8134: InPACT- International Penile Advanced Cancer Trial (International Rare Cancers Initiative study)

    Eligibility Criteria - NCT02305654 *This information has been extracted from " www.clinicaltrials.gov"

  • 20231126 - Sharma Janaki

  • Investigator:
    Janaki Sharma
    RCname Email

    Coordinator:

    IRB: 20231126

    SDG: GU
    Disease Site(s):

    Prostate

    Sponsor: NCTN

    Enrolling Sites:

    Sylvester

    Title:

    A Phase 2 Study of M1774 in Refractory SPOP-mutant Prostate Cancer

    Eligibility Criteria - NCT05828082 *This information has been extracted from " www.clinicaltrials.gov"

  • 20240124 - Sharma Janaki

  • Investigator:
    Janaki Sharma
    RCname Email

    Coordinator:

    IRB: 20240124

    SDG: GU
    Disease Site(s):

    Bladder

    Sponsor: NCI

    Enrolling Sites:

    Aventura
    Deerfield
    Gables
    Kendall
    Plantation
    Sylvester

    Title:

    MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of ADjuvant ThErapy in URothelial CaNcer

    Eligibility Criteria - NCT05987241 *This information has been extracted from " www.clinicaltrials.gov"